Stock INDEX INDEX PHARMACEUTICALS HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up

Insiders InDex Pharmaceuticals Holding AB

Equities

INDEX

SE0008966295

Delayed Nasdaq Stockholm
Other stock markets
 08:17:36 15/05/2024 BST 		5-day change 1st Jan Change
0.411 SEK +0.49% Intraday chart for InDex Pharmaceuticals Holding AB +0.25% +59.77%
05-07 InDex Pharmaceuticals Holding AB Approves the Election of Karl Tobieson as Board Member CI
04-26 InDex Pharmaceuticals Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
InDex Pharmaceuticals Holding AB Approves the Election of Karl Tobieson as Board Member
CI
Index Pharmaceuticals Holding AB Announces Board Resignations
CI
InDex Pharmaceuticals CEO, CFO to Step Down as Operations Cease
MT
Index Pharmaceuticals Holding AB Announces Resignation of Johan Giléus as Deputy CEO
CI
InDex Pharmaceuticals Holding AB Announces Resignation of Jenny Sundqvist as CEO, Effective September 26, 2024
CI
InDex Pharmaceuticals Holding AB Announces Composition of the Nomination Committee
CI
InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2023 Annual General Meeting
AQ
InDex Pharmaceuticals Holding AB Announces Appointment of Nomination Committee for the 2023 Annual General Meeting
CI
InDex Pharmaceuticals Holding AB Appoints Jenny Sundqvist as New CEO, Effective January 1, 2023
CI
InDex Pharmaceuticals Holding AB Announces Board Appointments
CI
InDex Pharmaceuticals Names New Chief Development Officer, Chief Medical Officer
MT
InDex Pharmaceuticals Strengthens the Organization with Eva Arlander as Chief Development Officer and Announces Changes in the Composition of the Management Team
CI
InDex Pharmaceuticals CEO Resigns
MT
InDex Pharmaceuticals Holding AB Announces CEO Changes
CI
InDex Pharmaceuticals COO To Step Down To Pursue WntResearch CEO Post
MT
InDex Pharmaceuticals Holding AB Announces Resignation of Pernilla Sandwall as Chief Operating Officer
CI
InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2022 Annual General Meeting
AQ
Index Pharmaceuticals Holding AB Announces Composition of Nomination Committee
CI
Index Pharmaceuticals : Names Heads For Phase III Cobitolimod Trials
MT
InDex Pharmaceuticals Holding AB Announces Appointment of Anders Bröijersén Is Joining Index as Senior Medical Director Clinical Operations and Johan Levin as Project Manager Clinical Operations
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. INDEX Stock
  4. News InDex Pharmaceuticals Holding AB
  5. Insiders